24.06.2024 13:15:52 - dpa-AFX: *BIONTECH, DUALITYBIO RECEIVE FDA FAST TRACK DESIGNATION FOR BNT324/DB-1311 IN PROSTATE CANCER

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
BIONTECH SE SPON. ADRS 1 A2PSR2 Frankfurt 74,200 02.08.24 20:33:32 -0,700 -0,93% 0,000 0,000 75,750 74,200

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH